TickerFacts.

Abpro Holdings, Inc. (ABPO): Shareholders' Equity

Annual figures by period end, from SEC filings.

-$8.83M
As of 2025-12-31
-$3.53M
As of 2026-06-30
$23.2K2021-12-31: $23.2K2022-12-31: -$11.18M2023-12-31: -$88.98M2024-12-31: -$15.49M2025-12-31: -$8.83M-$8.83M
2021-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31-$8.83Mn/m2026-04-15, Balance as of period end
2024-12-31-$15.49Mn/m2026-04-15, Balance as of period end
2023-12-31-$88.98Mn/m2025-04-15, Balance as of period end
2022-12-31-$11.18Mn/m2024-04-01, Balance as of period end
2021-12-31$23.2Kn/a2023-04-03, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Abpro Holdings, Inc. (ABPO)2025-12-31-$8.83Mn/m
Brainstorm Cell Therapeutics Inc. (BCLI)2025-12-31-$9.98Mn/m
Zeo ScientifiX, Inc. (ZEOX)2025-10-31-$1.42Mn/m
Zivo Bioscience, Inc. (ZIVO)2024-12-31-$514.9Kn/m
Adaptin Bio, Inc. (APTN)2025-12-31-$1.49Mn/m
Liminatus Pharma, Inc. (LIMN)2025-12-31-$9.81Mn/m
Estrella Immunopharma, Inc. (ESLA)2025-12-31-$10.37Mn/m
BioCardia, Inc. (BCDA)2025-12-31$895.0K+6.9%
Cero Therapeutics Holdings, Inc. (CERO)2025-12-31-$5.45Mn/m

Compare ABPO, BCLI, ZEOX, ZIVO side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗